These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16644752)

  • 41. Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [
    Nørgaard M; Ganz M; Svarer C; Frokjaer VG; Greve DN; Strother SC; Knudsen GM
    Neuroimage; 2019 Oct; 199():466-479. PubMed ID: 31158479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positron emission tomography imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studies.
    Narendran R; Frankle WG; Mason NS; Laymon CM; Lopresti BJ; Price JC; Kendro S; Vora S; Litschge M; Mountz JM; Mathis CA
    Synapse; 2009 Jul; 63(7):574-84. PubMed ID: 19301416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans.
    Lohith TG; Zoghbi SS; Morse CL; Araneta MD; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
    Neuroimage; 2014 Feb; 87():89-95. PubMed ID: 24225488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.
    Naganawa M; Zheng MQ; Henry S; Nabulsi N; Lin SF; Ropchan J; Labaree D; Najafzadeh S; Kapinos M; Tauscher J; Neumeister A; Carson RE; Huang Y
    J Nucl Med; 2015 Feb; 56(2):243-8. PubMed ID: 25593119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using (11)C-DASB and (11)C-MDL100907.
    Rylands AJ; Hinz R; Jones M; Holmes SE; Feldmann M; Brown G; McMahon AW; Talbot PS
    Biol Psychiatry; 2012 Dec; 72(12):1004-11. PubMed ID: 22835812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal duration of PET studies with 18F-fluoroethyl-diprenorphine.
    Boecker H; Sprenger T; Henriksen G; Toelle TR; Spilker ME
    J Nucl Med; 2005 Dec; 46(12):2092-6. PubMed ID: 16330575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PET [11C]DASB imaging of serotonin transporters in patients with alcoholism.
    Brown AK; George DT; Fujita M; Liow JS; Ichise M; Hibbeln J; Ghose S; Sangare J; Hommer D; Innis RB
    Alcohol Clin Exp Res; 2007 Jan; 31(1):28-32. PubMed ID: 17207098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?
    Kish SJ; Furukawa Y; Chang LJ; Tong J; Ginovart N; Wilson A; Houle S; Meyer JH
    Nucl Med Biol; 2005 Feb; 32(2):123-8. PubMed ID: 15721757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Test-retest reproducibility of quantitative binding measures of [
    McGinnity CJ; Riaño Barros DA; Rosso L; Veronese M; Rizzo G; Bertoldo A; Hinz R; Turkheimer FE; Koepp MJ; Hammers A
    Neuroimage; 2017 May; 152():270-282. PubMed ID: 28292717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP.
    Riaño Barros DA; McGinnity CJ; Rosso L; Heckemann RA; Howes OD; Brooks DJ; Duncan JS; Turkheimer FE; Koepp MJ; Hammers A
    Neuroimage; 2014 Aug; 97():151-62. PubMed ID: 24736184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo quantification of the [(11)C]DASB binding in the normal canine brain using positron emission tomography.
    Taylor O; Van Laeken N; De Vos F; Polis I; Bosmans T; Goethals I; Achten R; Dobbeleir A; Vandermeulen E; Baeken C; Saunders J; Peremans K
    BMC Vet Res; 2015 Dec; 11():308. PubMed ID: 26704517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei: An ultra-high resolution PET-MRI study.
    Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Joo YH; Kim YB; Cho ZH
    Brain Res; 2015 Dec; 1629():63-71. PubMed ID: 26459992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
    Frankle WG; Robertson B; Maier G; Paris J; Asmonga D; May M; Himes ML; Mason NS; Mathis CA; Narendran R
    Synapse; 2018 Mar; 72(3):. PubMed ID: 29216407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans.
    Hesse S; Brust P; Mäding P; Becker GA; Patt M; Seese A; Sorger D; Zessin J; Meyer PM; Lobsien D; Laudi S; Habermann B; Füchtner F; Luthardt J; Bresch A; Steinbach J; Sabri O
    Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1001-11. PubMed ID: 22349718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Test-retest reproducibility of 18F-MPPF PET in healthy humans: a reliability study.
    Costes N; Zimmer L; Reilhac A; Lavenne F; Ryvlin P; Le Bars D
    J Nucl Med; 2007 Aug; 48(8):1279-88. PubMed ID: 17631552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography.
    Wilson AA; Ginovart N; Hussey D; Meyer J; Houle S
    Nucl Med Biol; 2002 Jul; 29(5):509-15. PubMed ID: 12088720
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography.
    Spies M; James GM; Berroterán-Infante N; Ibeschitz H; Kranz GS; Unterholzner J; Godbersen M; Gryglewski G; Hienert M; Jungwirth J; Pichler V; Reiter B; Silberbauer L; Winkler D; Mitterhauser M; Stimpfl T; Hacker M; Kasper S; Lanzenberger R
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):145-153. PubMed ID: 29045739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys.
    Ichise M; Vines DC; Gura T; Anderson GM; Suomi SJ; Higley JD; Innis RB
    J Neurosci; 2006 Apr; 26(17):4638-43. PubMed ID: 16641244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tracer kinetic modeling of [(11)C]AFM, a new PET imaging agent for the serotonin transporter.
    Naganawa M; Nabulsi N; Planeta B; Gallezot JD; Lin SF; Najafzadeh S; Williams W; Ropchan J; Labaree D; Neumeister A; Huang Y; Carson RE
    J Cereb Blood Flow Metab; 2013 Dec; 33(12):1886-96. PubMed ID: 23921898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetic Modeling and Test-Retest Reproducibility of
    Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
    J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.